8-K: Strive to Acquire Semler Scientific in All-Stock Merger

Strive, Inc. has entered into a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction, with Semler Scientific shareholders receiving 21.05 shares of Strive Class A Common Stock for each share held.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Sci) have entered into an Agreement and Plan of Merger dated September 22, 2025.
• A newly formed subsidiary of Strive will merge with Semler Sci, with Semler Sci surviving as a wholly-owned subsidiary of Strive. Immediately following, Semler Sci will merge into a Delaware LLC, which will survive as a direct, wholly-owned subsidiary of Strive.
• The transaction is intended to qualify as a tax-free reorganization under Section 368(a) of the U.S. Internal Revenue Code.
• Each outstanding share of Semler Sci common stock (excluding treasury and Strive-held shares) will be converted into the right to receive 21.05 shares of Strive Class A Common Stock.
• Semler Sci equity awards (options) will be converted into options to purchase Strive Class A Common Stock, maintaining original terms, but with accelerated vesting under specific conditions (non-employee directors or termination without cause post-merger).
• The Boards of Directors of both Strive and Semler Sci unanimously approved the merger agreement.
• The merger is subject to customary closing conditions, including stockholder approvals from both companies and regulatory clearances (HSR Act).
• Semler Sci will pay Strive a termination fee of $49 million (cash or Bitcoin at Strive's election) under certain specified circumstances, such as a change in recommendation or if a superior proposal leads to a transaction within one year of termination.

Sentiment

Score: 7

Explanation: The definitive merger agreement, unanimously approved by both boards, indicates a clear path forward for a strategic transaction. The tax-free reorganization structure and the integration of Semler Scientific's Bitcoin holdings into Strive's digital asset strategy present potential long-term benefits. However, the inherent risks of integration, market volatility for digital assets, and the potential for a significant termination fee introduce some caution.

Positives

• Unanimous board approval from both Strive and Semler Sci indicates strong internal support for the transaction.
• The transaction is structured as a tax-free reorganization for U.S. federal income tax purposes, which can be beneficial for shareholders.
• The merger is expected to yield strategic and financial benefits, including anticipated cost savings and successful integration.
• Eric Semler, a director of Semler Scientific, is expected to join Strive's Board of Directors, potentially bringing valuable experience and continuity.
• Semler Scientific's significant Bitcoin holdings (at least 5,021 Bitcoin) will be integrated into Strive, potentially enhancing Strive's digital asset strategy.

Negatives

• The agreement includes a $49 million termination fee payable by Semler Sci to Strive under certain conditions, which could deter competing offers or penalize Semler Sci if the deal falls through due to its actions.
• The 'Burdensome Condition' clause allows Strive to avoid divestitures or other actions that would limit its freedom of action to secure regulatory approval, potentially prolonging or complicating the HSR review process if significant antitrust concerns arise.
• The merger involves the issuance of a substantial number of Strive Class A Common Stock shares, which will result in dilution for existing Strive shareholders.
• Risks associated with Bitcoin and other digital assets, as well as general economic and market conditions, could impact the combined company's future financial performance.

Risks

• Failure to obtain necessary stockholder approvals from either Semler Scientific or Strive.
• Failure to satisfy other customary closing conditions, including regulatory approvals (e.g., HSR Act clearance).
• The possibility that the proposed transaction does not close when expected or at all.
• Potential legal proceedings against Strive or Semler Scientific or the combined company related to the merger.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected, partly due to changes in or problems arising from Bitcoin treasury strategies and risks associated with digital assets.
• Integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional Class A common stock.
• Potential adverse reactions from customers or changes to business or employee relationships due to the announcement or completion of the merger.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The companies intend for the merger to constitute a tax-free reorganization and expect strategic and financial benefits, including anticipated cost savings and successful integration of the combined businesses. However, the outlook is subject to risks related to Bitcoin treasury strategies, general economic and market conditions, interest and exchange rates, monetary policy, laws and regulations, and potential difficulties in integration.

Management Comments

• Entry into the Merger Agreement was unanimously approved by the Board of Directors of each of Strive and Semler Sci.
• The Board of Directors of the Company has unanimously determined that this Agreement and the transactions contemplated hereby (including the Merger) are advisable, fair to and in the best interests of the Company’s stockholders.

Industry Context

This merger represents a strategic move by Strive, a company with a significant digital asset strategy (evidenced by its Bitcoin holdings and focus on Bitcoin treasury strategies), to acquire Semler Scientific, a medical device company known for its QuantaFlo product, which also holds a substantial amount of Bitcoin. This could indicate a trend of companies diversifying their treasury assets into digital currencies or a strategic acquisition by Strive to expand its digital asset portfolio and potentially integrate it with a new business sector, or simply acquire Semler Sci for its Bitcoin holdings and then divest the medical device business. The filing highlights the risks associated with Bitcoin and digital assets, reflecting the evolving regulatory and market landscape for such holdings.

Management Changes

Corporate Governance

Legal Proceedings

• The agreement mentions 'Transaction Litigation' as a potential risk, referring to stockholder demands, litigations, arbitrations, or other similar proceedings commenced against the company and/or its directors or officers relating to the agreement or transactions.
• Both parties commit to cooperate and use reasonable best efforts to defend against such proceedings.

Related Party Transactions

• The filing defines 'Related Party Contract' as any contract or transaction with an executive officer, director, 5% beneficial owner, or their affiliates/associates. However, no specific related party transactions are detailed in the main 8-K filing itself.

Stakeholder Impact

• Shareholders (Semler Scientific): Will receive 21.05 shares of Strive Class A Common Stock for each share held, representing the merger consideration. Their equity awards will convert to Strive options.
• Shareholders (Strive): Will experience dilution due to the issuance of new Class A Common Stock for the merger consideration.
• Employees (Semler Scientific): Options will convert to Strive options with similar terms, and certain employees may see accelerated vesting under specific conditions. For 12 months post-closing, affected employees will receive comparable base salary/wage, target cash incentives, and other benefits (excluding certain types). Service credit will be recognized for vesting and eligibility in Strive's plans.
• Management (Semler Scientific): Eric Semler, a director, will join Strive's board.
• Creditors (Semler Scientific): The company will provide notices and documents related to its convertible notes indenture, and Strive will make funds available if notes are amended, redeemed, or satisfied.
• Regulatory Bodies: The merger requires HSR Act clearance and SEC filings (Form S-4, proxy statement).

Next Steps

• Strive to form a Merger Sub and Second Merger Sub.
• Strive and Semler Scientific to jointly prepare and file a Registration Statement on Form S-4 (including an Information Statement/Proxy Statement/Prospectus) with the SEC.
• Semler Scientific to convene a stockholder meeting to obtain the necessary stockholder approval for the merger.
• Strive to obtain stockholder approval for the issuance of its Class A Common Stock in connection with the merger.
• Obtain regulatory clearances, including the expiration or termination of the HSR Act waiting period.
• Strive to ensure its Class A Common Stock to be issued in the merger is approved for listing on Nasdaq.
• Eric Semler (Semler Scientific director) to be appointed to Strive's Board of Directors, subject to Nasdaq independence criteria.
• Integration of Semler Scientific into Strive's operations post-merger.
• Semler Scientific to provide timely notices and documents to the trustee under its indenture for convertible notes.
• Both companies to cooperate on any ATM financing.

Key Dates

Recommendation

This is a definitive merger agreement, which typically provides a clear path for the acquired company's shareholders to realize value based on the exchange ratio. For Strive, the acquisition of Semler Scientific, including its significant Bitcoin holdings, represents a strategic expansion or consolidation of its digital asset strategy. The unanimous board approvals suggest confidence in the deal's strategic rationale. However, the success of the merger hinges on successful integration, realization of anticipated synergies, and the performance of digital assets, which carry inherent volatility. Investors should hold existing positions and monitor the integration process, regulatory approvals, and the performance of the combined entity, especially concerning its digital asset strategy, before making further investment decisions.

Keywords

Merger, Acquisition, Strive Inc., Semler Scientific, All-Stock Deal, SEC Filing, 8-K, Corporate Reorganization, Bitcoin Strategy, Digital Assets, Healthcare Technology, QuantaFlo, Nasdaq